WHO ICTRP trial
Observation on the application effect of remazolam and propofol in elderly…
ChiCTR2100055039 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100055039 |
|---|---|
| Public title | Observation on the application effect of remazolam and propofol in elderly patients with hip replacement surgery |
| Scientific title | Observation on the application effect of remazolam and propofol in elderly patients with hip replacement surgery |
| Primary sponsor | The Second People's Hospital of Hefei |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Interventions | Remazolam group:Remazolam 0.2-0.4 mg/kg IV during induction of general anesthesia;Propofol group:Propofol 1.5-2 mg/kg bolus was selected during induction |
| Registration date | Dec 31, 2021 |
| Target size | Remazolam group:30;Propofol group:30 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: